As told to Parliament (March 14, 2023): After Uzbekistan cough syrup deaths, Centre cautioned pharma units

All that was discussed in the House through the day

When Big Pharma has all the answers

IFPMA, the biopharma trade body, has made its claim clear: COVID-19 vaccine management should be left to these handful of companies; and all …

Trial by hire

Laissez-faire in clinical research has unleashed a ruthless profit-making machine blind to notions of justice or equity. It is time to rein in …

Indian pharma firms receive 34% of FDA warnings this year

These warnings were for misbranding, selling unapproved medicines and violating Current Good Management Practices

National List of Essential Medicines: 34 drugs enlisted in update after 7 years

The latest National List of Essential Medicines features 384 medicines, drops 26 old ones

Why Americans pay more for prescription drugs than anywhere else globally

The root of the problem is a patent system that allows pharma companies to keep out competition and keep prices sky high

India to set up 10 pharma clusters across country

The move will reduce cost of production of medicines by up to 25 per cent

Antimicrobial resistance: Here is how pharma companies can reduce antibiotic pollution in effluents

There is a high risk of antibiotic residues entering the environment from wastewater used in manufacturing pharmaceuticals

FDI in pharma: Cabinet clears KKR investments in two Indian drug firms

Union health and commerce ministries have been opposing such investment without safeguards for acquisition of domestic critical care pharma firms

US sound and fury over drug prices

The US Senate is outraged by the rapacious pricing policy of drug firms but will it act to reform the system?

Sun Pharma to buy troubled giant Ranbaxy

The combined entity will create India’s largest pharma company and world’s fifth-largest specialty generics company

Profits and not improving accessibility matter to Indian drug makers

FICCI conference organised to discuss access to generic medicines focuses more on increasing exports

Antibiotic residues in wastewater may trigger antimicrobial resistance in India, China: Study

Antimicrobial resistance results in an increase in morbidity, mortality and healthcare costs for the individual, health system and country

Delhi High Court scraps ban on 344 fixed combination drugs

Health ministry banned 344 fixed combination drugs in March fearing antimicrobial resistance and other health hazards

Single nanoparticle twists pave the way for medicines on demand: Study

Understanding chirality — twists within nanoparticles — can help several industries, including pharma 

Pharma’s dirty deals to stall generics

As generic companies, including Indian firms, collude with innovator pharma giants in pay-for-delay pacts, consumers pay a high price

Remdisivir shows no benefits on COVID-19 patients in first clinical trial

Lancet paper contradicts Gilead results on drug which claimed improvement in patients  

Finally, antiviral drug for dengue in the offing

World’s first botanical drug against dengue is in the final stage of development at the Delhi-based International Centre for Genetic …

Government stand against EU ban on Indian drugs much needed, says industry

Standing against the arbitrary ban on 700 drugs, India has decided to defer the proposed talks on the free trade agreement between India and the EU

When generics turn into Big Pharma

Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims  

AI for drug development: How trustworthy is the tech?

Pharma companies today deploy artificial intelligence with a potential to reduce the drug development cycle by half 

D Srinivasa Reddy takes over as Director CSIR-IICT

Reddy will also hold the additional charge of the post of director of CSIR-IIIM, Jammu and director, CSIR-CDRI, Lucknow

Beware of a deal with Trump

As the US president comes visiting to India there is worry about the demands he will make on intellectual property

Software outsmarts drug research

Now, a programme can bypass patented drug pathways and create synthetically-produced medicines

Ranbaxy effect: Indian government defends pharma industry

Few isolated cases cannot undermine well regulated system, says commerce ministry